Login to Your Account

Clinic Roundup

Thursday, August 8, 2013
• Cleveland Biolabs Inc., of Buffalo, N.Y., began enrolling in a Phase I trial of CBL0137, for metastatic or unresectable advanced solid cancers and lymphomas.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription